Asklepios Klinik Sankt Augustin GmbH — Clinical Trial Site

30 Registered trials

17 Currently recruiting

Organisation

Asklepios Klinik Sankt Augustin GmbH

Location

Sankt Augustin, Germany

Identifier

ORG-100025810

Address

Arnold-Janssen-Straße 29, 53757, Germany

Departments

#40787: Center of General Paediatrics and Neonatology
2601: Abteilung der Kinder- und Jugendmedizin
4003:Kinderklinik
Allgemeine Kinder- und Jugendmedizin
Allgmeine Kinderheilkunde
Center for General Paediatrics and Neonatology
Center of General Paediatrics and Neonatology
Department of Pediatrics
Hematology and oncology
Kinder- und Jugendmedizin Kinder-Hämatologie und Onkologie
Kinder-Hämatologie und Onkologie
Kinderonkologie
Klinik für Kinder und Jugendmedizin
N/A
Onkologie und Hämatologie
Pädiatrie
Pädiatrische Hämatologie und Onkologie
Pädiatrische Onkologie
Pädiatrische Onkologie und Hämatologie
Paedriatrics, Department of Oncology and Hematology
Pediatric department
Pediatric Hematology/Oncology
Pediatric rheumatology, immunology
Pediatrics
Zentrum Allgemeine Kinderheilkunde und Neonatologie

Clinical trials at this site (30)

Search interface

SIOP PNET 5 medulloblastoma Pending

2024-513724-42-00 Medulloblastoma 10
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending

2024-517295-37-00 low and intermediate risk neuroblastoma 5
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA) Pending

2025-520923-25-00 Juvenile Idiopathic Arthritis 5
Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Polyarticular-course juvenile idiopathic arthritis 5 2026-04-27
A study of anifrolumab in children and adolescents (5 to < 18 years old) with moderate to severe lupus to find the appropriate anifrolumab d… Recruiting

2022-502289-25-00 Moderate to Severe Active Systemic Lupus Erythematosus 5 2024-08-28
Efficacy, safety, tolerability, and pharmacokinetics of risankizumab in pediatric subjects with active juvenile psoriatic arthritis Recruiting

2023-506026-36-00 Juvenile Psoriatic Arthritis 5 2024-04-29
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and how Drug Move… Recruiting

2022-501599-25-00 juvenile idiopathic arthritis 5 2024-03-19
Evaluation of the Pharmacokinetics and Safety of Upadacitinib in Pediatric Subjects with Polyarticular Course Juvenile Idiopathic Arthritis … Recruiting

2023-505060-11-00 Polyarticular Course Juvenile Idiopathic Arthritis 3 2019-06-19
Open-label extension study with filgotinib in children with juvenile idiopathic arthritis. Recruiting

2025-523239-21-00 Juvenile idiopathic arthritis 5 2026-04-13
An open-label phase II trial to evaluate the clinical efficacy, safety and tolerability of MAS825 in pediatric and adult participants with S… Recruiting

2024-520208-25-00 Still’s disease 4 2026-01-15
A study to learn if bimekizumab is safe and how it moves throughout the body in children with certain types of juvenile idiopathic arthritis Recruiting

2023-508845-41-00 Active juvenile idiopathic arthritis subtypes enthesiti 5 2025-03-11
A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Moderately to severely active ulcerative colitis (UC) 5 2024-10-29
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Juvenile psoriatic arthritis 5 2021-03-31
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JUVE-X) Recruiting

2023-506131-15-00 Juvenile Idiopathic Arthritis 5 2019-09-10
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA) Recruiting

2024-512701-11-00 Systemic Juvenile Idiopathic Arthritis (sJIA) 4 2018-08-29
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juven… Ended

2023-507184-19-00 Juvenile Psoriatic Arthritis  Enthesitis Related Arthr 5 2021-02-22
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 acute lymphoblastic leukemia in children and adolescent 5 2018-07-15